We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Studio Pictures Ltd is a UK-based film and TV production company founded by producers Adam Rolston and David Braithwaite in 2019. Specializing in creating high-quality British entertainment content, the company focuses on adapting books to screen and telling unique true-life stories that entertain and inspire both domestic and international audiences. With successful productions like "A Street Cat Named Bob," the company is building a strong brand and reputation in the industry. Studio Pictures has access to top creative talent and collaborates with major studios like Warner Bros, Sony Pictures, Lionsgate, and Studio Canal. The company is located at Twickenham Studios in Richmond, UK.
days to go: 32 investment: Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go: Stretch investment: Withheld
Liquid supplements are a faster acting and a more efficient way for the body to absorb key active ingredients than taking pills. Our scientists have developed formulations involving leading active ingredients such as collagen in order to create the perfect wellness solution in every bottle. Each LQ bottle is packed full of 9 or more active ingredients all in one easy to drink, daily 50 m bottle.
days to go: Expired investment: £355,000
Howsy is an online marketplace for renting. Howsy does away with traditional over-priced and under-serviced lettings model, bringing down the cost of managing a property by an estimated 75%. Their team of 81, operate across three locations—two in the UK and one in South East Asia. The company has also been featured in publications such as Forbes and The Guardian as well as portals such as TechCityNews and Startups.co.uk. The company will use the investment to build a digital service that makes renting easier, qualify for the 'Future Fund', a government support package for start-ups, and towards building working capital and growth marketing.
days to go: Expired investment: £2,346,770
StepJockey are aiming to create healthier, more active buildings by labeling the stairs of the world for calorie burn. StepJockey are encouraging people to take the stairs as opposed to the elevator.
days to go: Expired investment: £280,370
Sunswap is a solar and battery-powered transport refrigeration company that keeps food, medicine, and vaccines cold whilst on the road. The company argues that diesel-powered Transport Refrigeration Units (TRUs) are expensive to operate and highly polluting. It proclaims that replacing a diesel TRU with a Sunswap TRU could be the equivalent of removing 31 cars from the road. Sunswap asserts that the TRU market would have a market worth £13.4 billion by 2030. The company aims to be a contender in this segment and claims that electric TRU sales will follow the electric vehicle adoption curve with a 60% Year-on-Year growth. Sunswap has successfully tested its working prototype's capability to meet the temperature requirements of -22°C. It is collaborating with six major UK supermarkets on product development, with aims to secure sales with them in 2021. The company will use the investment to grow its team, build the next generation product, and secure sales by the end of 2021.
days to go: Expired investment: £535,000
Maecenas is a fine art investment platform, allowing collectors to raise funds and investors to own a piece of fine art they would not normally be able to afford such as a picasso or even a Rembrandt! The investment made in the Artwork can easily be re-sold using the Maecenas platform and all investments are fully protected by insurance and a strong legal framework. 
days to go: Expired investment: £218,249
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph